Applied DNA Sciences Inc. (APDN) and TheraCann International Benchmark Corp., a cannabis and hemp consultancy, said Friday that they have entered into an exclusive licensing and cooperation agreement for a cannabis tracking system. Shares of Applied DNA gained almost 32 percent in Friday’s trading following the announcement.

Under the agreement, TheraCann’s wholly-owned subsidiary, ETCH BioTrace, S.A., has been granted the use of Applied DNA’s CertainT supply chain integrity platform technology within the global legal cannabis and hemp markets.